Inhibition of histone methyltransferase PRMT5 attenuates cisplatin-induced hearing loss through the PI3K/Akt-mediated mitochondrial apoptotic pathway.

Authors:
Zheng Z; Nan B; Liu C; Tang D; Li W and 3 more

Journal:
J Pharm Anal

Publication Year: 2023

DOI:
10.1016/j.jpha.2023.04.014

PMCID:
PMC10334280

PMID:
37440906

Journal Information

Full Title: J Pharm Anal

Abbreviation: J Pharm Anal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that there are no conflicts of interest."

Evidence found in paper:

"This work was supported by grants from the 10.13039/501100001809National Natural Science Foundation of China (Grant Nos.: 82271158, 82192865, and 82071045), and Wenzhou Municipal Science and Technology Research Program (Grant No.: 2021Y0681). This work was supported by grants from the 10.13039/501100001809National Natural Science Foundation of China (Grant Nos.: 82271158, 82192865, and 82071045), and Wenzhou Municipal Science and Technology Research Program (Grant No.: 2021Y0681)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025